Table 3.
Prevalence of Functional Gastrointestinal Dyspepsia (Rome III Criteria)
| Study | Sample size | Subject group (Method of data collection) | Country | Age | PrevalenceTotal (M/F) (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| UD | IBS | AB | Constipation | Diarrhea | UBD | APS | |||||
| Sorouri et al,33 2010 | 18 180 | GP (Interview) | Iran | 16–80 | 8.9(−/−) | 1.1(0.6/1.5) | 1.5 (1.4/1.7) | 2.4 (1.2/3.7) | 0.2(0.2/0.3) | 5.5(4.3/6.7) | - |
| Chang et al,14 2012 | 4275 | GP (Interview) | Taiwan | 19 ≤ | 5.3 (4.4/6.3) | 4.4 (3.4/5.4) | 2.1 (1.3/3.0) | 4.4 (2.8/6.2) | 2.2 (2.7/1.7) | 8.9 (7.6 /10.2) | 0.4 (0.2/0.5) |
M, male; F, female; UD, uninvestigated dyspepsia; IBS, irritable bowel syndrome; AB, abdominal bloating UBD, unspecified bowel disorder; APS, abdominal pain syndrome; GP, general population; -, not assessed.